Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Orsolya, Mucsi"'
Autor:
Júlia, Gaál-Weisinger, Orsolya, Mucsi, Gábor, Körösmezey, Balázs, Szili, Hanna, Eid, Richárd, Kiss, Csaba, Bödör, Ilona, Tárkányi, Zsolt, Nagy, Judit, Demeter
Publikováno v:
Magyar onkologia. 61(1)
The introduction of tyrosine kinase inhibitor (TKI) treatment has resulted in dramatically improved survival in chronic myeloid leukemia (CML). With the new generation of TKIs the majority of patients reach optimal molecular response. Due to the impr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ff7eb615c19e732d462e39c6e7e259f
https://pubmed.ncbi.nlm.nih.gov/28273190
https://pubmed.ncbi.nlm.nih.gov/28273190
Autor:
Anna Orsolya, Mucsi, Zsolt, Nagy
Publikováno v:
Magyar onkologia. 61(1)
Waldenström's macroglobulinemia is a rare, low-grade non-Hodgkin lymphoma of B cell origin, most common in elderly male patients with a median age of 64 years at diagnosis. It accounts for approximately 2% of hematologic malignancies. The disease is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b26d346ad7ebc796810b78eb5ab7ec66
https://pubmed.ncbi.nlm.nih.gov/28273184
https://pubmed.ncbi.nlm.nih.gov/28273184
Autor:
Orsolya, Mucsi
Publikováno v:
Magyar onkologia. 60(2)
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western countries. The abnormal B lymphocytes progress into the blood and infiltrate the bone marrow, liver, spleen and lymph nodes. CLL is a disease of the adults and older indivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c1b287e28abbbecd5f39f0b870ea822
https://pubmed.ncbi.nlm.nih.gov/27275639
https://pubmed.ncbi.nlm.nih.gov/27275639